EU body backs Novartis' Galvus, Eucreas for diabetes indications (Reuters, 21 September 2012)
24 Sept 2012
The European Medicines Agency has issued a positive opinion for new indications of two AG Novartis drugs Galvus and Eucreas in patients with type II diabetes.